Although amyotrophic lateral sclerosis (ALS) was identified as a neurological condition 150
years ago, risk factors related to the onset and progression of ALS remain largely unknown …

Abstract Problem/Condition: Amyotrophic lateral sclerosis (ALS), commonly known as Lou
Gehrig's disease, is a progressive and fatal neuromuscular disease for which no cure or …

Objective: We set up the Swedish Motor Neuron Disease (MND) Quality Registry to assure
early diagnosis and high-quality health care for all MND patients (mainly amyotrophic lateral …

Understanding patient clinical progression is a key gateway to planning effective clinical
trials and ultimately enabling bringing treatments to patients in need. In a rare disease like …

Background Environmental exposures contribute to the pathogenesis of amyotrophic lateral
sclerosis (ALS), a fatal and progressive neurological disease. Identification of these …

Neurodegenerative diseases are becoming prevalent as the population ages. Geniposide
could inhibit oxidative stress, reduce apoptosis, protect neuron, and has been used for …

Objective: To estimate risks of neurodegenerative and psychiatric diseases among patients
with amyotrophic lateral sclerosis (ALS) and their families. Methods: We conducted a …

Amyotrophic Lateral Sclerosis (ALS) is a complex and rare neurodegenerative disease
given its heterogeneity. Despite being known for many years, few countries have accurate …

Objective: Neurotoxic chemicals are suggested in the etiology of amyotrophic lateral
sclerosis (ALS). We examined the association of environmental and occupational risk factors …

Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a rapidly
progressive fatal neurologic disease. Currently, there is no cure for ALS and the available …